Mariya Rozenblit

Mariya Rozenblit, MD, is an Assistant Professor of Medicine in the Medical Oncology department at Yale School of Medicine. Her clinical focus is on treating patients with various stages of breast cancer, including ductal carcinoma in situ (DCIS) and metastatic breast cancer. She completed her medical degree at Icahn School of Medicine at Mount Sinai (2015), residency in Internal Medicine at NYU Langone (2018), and a Fellowship in Medical Oncology-Hematology at Yale.

Her research focuses on biomarker-driven clinical trials in breast cancer, particularly in understanding genetic and molecular factors influencing disease progression and treatment response. Notable achievements include the 2020 ASCO Conquer Cancer Foundation Young Investigator Award and the 2022 Susan G. Komen Career Catalyst Grant.

Rozenblit collaborates with institutions like the Center for Breast Cancer Genomics, Genetics, and Epigenetics. Her work emphasizes translational research, including studies on germline variants in high-risk patients and genomic alterations in young women with advanced breast cancer.

• Education:
  • Bachelor of Arts in Biology, Columbia University (2009)
  • MD, Icahn School of Medicine at Mount Sinai (2015)
  • Internal Medicine Residency, NYU Langone (2018)
  • Medical Oncology-Hematology Fellowship, Yale (2021)
• Awards:
  • ASCO Conquer Cancer Foundation Young Investigator Award (2020)
  • Susan G. Komen Career Catalyst Research Grant (2022)
• Clinical Trials: Leads and participates in trials targeting breast cancer treatment, including biomarker assessment and therapeutic efficacy studies.
• Research Interests: Germline variants, genomic profiling, and translational applications in breast cancer.